Eli Lilly LLY CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Eli Lilly's capex?
- Eli Lilly (LLY) reported capex of $2.33B in Q1 2026.
- How has Eli Lilly's capex changed year-over-year?
- Eli Lilly's capex increased by 54.0% year-over-year, from $1.51B to $2.33B.
- What is the long-term trend for Eli Lilly's capex?
- Over 4 years (2021 to 2025), Eli Lilly's capex has grown at a 56.4% compound annual growth rate (CAGR), from $1.31B to $7.84B.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.